Patent clarity for the future of health.
From biologics and gene therapies to medical devices and precision medicine, life sciences is one of the most complex and heavily patented industries. We help pharmaceutical companies, biotech firms, medtech innovators, and research institutions protect, clear, and monetize their groundbreaking innovations globally.
IP challenges in the life sciences industry
Life sciences is one of the most patent-intensive and regulated industries. Innovations in small molecules, monoclonal antibodies, gene therapies, cell therapies, CRISPR-based editing, companion diagnostics, and medical devices are protected by dense and overlapping patent portfolios spanning composition of matter, methods of use, manufacturing processes, and formulations.
The complexity is further increased by the long development timelines and high regulatory hurdles. Patent cliffs, evergreening strategies, biosimilar challenges, and international variations in patent eligibility (especially around natural products, diagnostic methods, and software-enabled inventions) create significant strategic challenges for both innovators and challengers.
Whether you are a pharmaceutical company developing a new therapy, a biotech startup advancing a novel platform, or a medtech firm launching a new device, early and thorough IP due diligence is essential to secure freedom-to-operate, strengthen your portfolio, and avoid costly litigation or regulatory delays.
How we support life sciences IP programs
Scientific depth combined with sophisticated patent analysis tailored to the life sciences industry.
Technical Disclosure & NDA Execution
We start with a robust confidentiality agreement and obtain detailed scientific and technical information about your molecule, therapy, device, or platform.
Technology & Jurisdiction Mapping
We map your innovation across relevant patent categories and target markets considering regulatory pathways and patent term extensions.
Patent Landscape & FTO Search
Comprehensive searches covering composition, method-of-use, formulation, manufacturing, and second-generation patents across global databases.
Claim-Level Risk Analysis
Our PhD scientists and patent attorneys perform detailed claim mapping against your product or process.
Report & Strategic Recommendations
You receive a clear, actionable report with risk assessment, design-around strategies, portfolio strengthening opportunities, and regulatory/IP alignment.
What you receive
Why life sciences companies need robust IP strategy
In life sciences, patents are the foundation of commercial success. With development costs often exceeding a billion dollars and long regulatory timelines, strong IP protection and careful freedom-to-operate analysis are critical to secure market exclusivity, attract investment, and defend against biosimilar and generic competition.
Free Consultation
Get a life sciences IP assessment within 24 hrs
Frequently asked questions
Due to extremely high development costs and long timelines, patents provide the necessary market exclusivity to recover investments. Strong IP strategy can determine the commercial success or failure of a new drug or medical technology.
Yes. We provide full IP lifecycle support — freedom-to-operate, patentability, landscape analysis, invalidity searches, and strategic portfolio development.
Small molecules, biologics, gene & cell therapy, CRISPR, mRNA, medical devices, diagnostics, drug delivery, vaccines, and precision medicine.
Most projects are completed within 7–14 business days. Complex biologics or multi-jurisdictional analyses may take longer.
Absolutely. Every engagement starts with a binding NDA and all information is handled with strict confidentiality protocols.
Ready to assess your life sciences IP position?
Get a thorough patent and IP analysis from technical experts with deep life sciences domain experience — delivered in 5–7 business days.